Government initiatives supporting chronic pain research are also playing a role in the growth of the CRPS market. Funding for neurological and pain-related studies is helping researchers explore new treatment possibilities. This support is essential for long-term market development. The Complex Regional Pain Syndrome (CRPS) Market is experiencing steady growth as the demand for effective...

One of the major factors driving the market is the rising prevalence of cancer globally. As chemotherapy remains one of the most widely used cancer treatments, the number of patients experiencing neuropathy symptoms such as numbness, tingling, and pain continues to increase. This trend directly contributes to the demand for CIPN treatments. The chemotherapy-induced peripheral neuropathy (CIPN)...